Prospera Financial Services Inc Vertex Pharmaceuticals Inc Transaction History

Prospera Financial Services Inc

$4.16 Billion
Q4 2024

A detailed history of Prospera Financial Services Inc transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Prospera Financial Services Inc holds 3,302 shares of VRTX stock, worth $1.65 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

3,302

Previous 13,498 75.54%

Holding current value

$1.65 Million

Previous $6.28 Million 78.83%

% of portfolio

0.03%

Previous 0.16%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	SELL	$396.64 - $516.74 $4.04 Million - $5.27 Million	-10,196 Reduced 75.54%	3,302 $1.33 Million
Q3 2024 Nov 07, 2024	BUY	$460.0 - $505.78 $5.04 Million - $5.54 Million	10,951 Added 429.96%	13,498 $6.28 Million
Q2 2024 Aug 13, 2024	SELL	$392.81 - $485.53 $27,889 - $34,472	-71 Reduced 2.71%	2,547 $1.19 Million
Q1 2024 Aug 13, 2024	BUY	$407.69 - $446.08 $79,907 - $87,431	196 Added 7.7%	2,743 $1.15 Million
Q4 2023 Feb 14, 2024	SELL	$343.0 - $410.68 $17,493 - $20,944	-51 Reduced 1.91%	2,618 $1.07 Million
Q3 2023 Nov 13, 2023	BUY	$338.18 - $362.46 $12,850 - $13,773	38 Added 1.44%	2,669 $928,000
Q2 2023 Aug 08, 2023	BUY	$314.42 - $351.91 $1,257 - $1,407	4 Added 0.15%	2,631 $925,000
Q1 2023 May 12, 2023	BUY	$283.23 - $323.1 $18,409 - $21,001	65 Added 2.54%	2,627 $827,000
Q4 2022 Feb 08, 2023	BUY	$285.76 - $321.48 $24,861 - $27,968	87 Added 3.52%	2,562 $739,000
Q3 2022 Oct 27, 2022	BUY	$273.83 - $305.53 $62,980 - $70,271	230 Added 10.24%	2,475 $716,000
Q2 2022 Aug 08, 2022	BUY	$234.96 - $292.55 $132,987 - $165,583	566 Added 33.71%	2,245 $633,000
Q1 2022 May 04, 2022	BUY	$221.42 - $260.97 $371,764 - $438,168	1,679 New	1,679 $438,000
Q4 2020 Feb 12, 2021	SELL	$207.01 - $276.09 $32,500 - $43,346	-157 Closed	0 $0
Q3 2020 Nov 04, 2020	SELL	$255.65 - $303.1 $136,772 - $162,158	-535 Reduced 77.31%	157 $43,000
Q2 2020 Aug 07, 2020	BUY	$225.48 - $295.8 $156,032 - $204,693	692 New	692 $201,000

Others Institutions Holding VRTX

# of Institutions

1,760

Shares Held

228M

Call Options Held

1.63M

Put Options Held

1.47M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $128B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Prospera Financial Services Inc, based on Form 13F filings with the SEC.

News

Stay updated on Prospera Financial Services Inc with notifications on news.

Account

Prospera Financial Services Inc Vertex Pharmaceuticals Inc Transaction History